3,000mg Pure CBD Oil Isolated Spectrum Tincture
Pure Hemp Botanicals’ Isolated Spectrum Pure Hemp Oil Tincture offers a great way to experience the benefits of hemp with non-detectable levels of THC. With 3,000mg per one-ounce bottle, each serving delivers 100mg of CBD derived from 100% industrial hemp. Serving size is 1 dropper (1 ml) with 30 servings per bottle.
5 in stock
This is a game-changing product for a lot of people! Isolated Spectrum means PURE CBD.
We’ve designed this so that there are non-detectable levels of THC.
Pure Hemp Botanical’s CBD Tincture contains only the finest quality purified cannabidiol made from Colorado grown industrial hemp. By using a pure isolated spectrum extract, this Tincture offers peace of mind with minimal trace amounts of other cannabinoids, in a convenient dropper bottle. This quick-absorbing tincture can be used during the day or evening as needed.
Pure Hemp Botanicals prides itself on producing the highest quality product available. Each product that is produced by Pure Hemp Botanicals is put through a rigorous testing process ensuring the quality of our end products.
Each product has a lab result number on it that correlates to our lab testing results which are available at the following link: LAB RESULTS Simply place your batch number into the search field (found on the product) and click search and direct link to the lab results for your product.
About Pure Hemp Botanicals CBD Tinctures
CBD Tincture is a fast-acting, controlled dose of high-quality cannabidiol that doesn’t require inhalation. This fast-absorbing tincture has a smooth, natural flavor that works best when placed under the tongue. It’s completely pure, free of additives and discreet for easy consumption.
*Fifteen THC-naïve adults ingested, over four successive 10-day periods, single daily THC doses ranging from 0.09 to 0.6 mg. Subjects self-administered THC in 15-mL aliquots (20 mL for the 0.6-mg dose) of four different blends of hemp and canola oils. Urine specimens were collected prior to the first ingestion of oil, on days 9 and 10 of each of the four study periods, and 1 and 3 days after the last ingestion. All specimens were screened for cannabinoids by radioimmunoassay (Immunalysis Direct RIA Kit), confirmed for THC-COOH by gas chromatography-mass spectrometry (GC-MS), and analyzed for creatinine to identify dilute specimens. None of the subjects who ingested daily doses of 0.45 mg of THC screened positive at the 50-ng/mL cutoff. At a daily THC dose of 0.6 mg, one specimen screened positive.